nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—CNR2—nervous system—attention deficit hyperactivity disorder	0.0267	0.144	CbGeAlD
Dronabinol—CNR2—central nervous system—attention deficit hyperactivity disorder	0.0257	0.138	CbGeAlD
Dronabinol—CNR2—brain—attention deficit hyperactivity disorder	0.0204	0.11	CbGeAlD
Dronabinol—CNR1—cerebellum—attention deficit hyperactivity disorder	0.0175	0.0941	CbGeAlD
Dronabinol—CNR1—brain—attention deficit hyperactivity disorder	0.0142	0.0764	CbGeAlD
Dronabinol—CYP2A6—cerebellum—attention deficit hyperactivity disorder	0.00679	0.0366	CbGeAlD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00638	0.00784	CbGpPWpGaD
Dronabinol—CNR2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00633	0.00777	CbGpPWpGaD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.0063	0.00774	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00622	0.00764	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00618	0.00759	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—HTR1B—attention deficit hyperactivity disorder	0.0061	0.00749	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00609	0.00748	CbGpPWpGaD
Dronabinol—CNR1—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.00609	0.00748	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00606	0.00745	CbGpPWpGaD
Dronabinol—PTGS1—forebrain—attention deficit hyperactivity disorder	0.00605	0.0326	CbGeAlD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00587	0.00721	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00574	0.00705	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00566	0.00695	CbGpPWpGaD
Dronabinol—CYP2C9—cardiovascular system—attention deficit hyperactivity disorder	0.00561	0.0302	CbGeAlD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00556	0.00683	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00555	0.00681	CbGpPWpGaD
Dronabinol—CYP2A6—brain—attention deficit hyperactivity disorder	0.00552	0.0297	CbGeAlD
Dronabinol—CNR1—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00549	0.00674	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00547	0.00671	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.0054	0.00663	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.0054	0.00663	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00538	0.00661	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00533	0.00654	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00526	0.00646	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00524	0.00643	CbGpPWpGaD
Dronabinol—PTGS1—cardiovascular system—attention deficit hyperactivity disorder	0.00512	0.0276	CbGeAlD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00509	0.00626	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00503	0.00618	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00501	0.00615	CbGpPWpGaD
Dronabinol—CNR1—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00496	0.0061	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00495	0.00607	CbGpPWpGaD
Dronabinol—CYP1A1—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00493	0.00605	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00485	0.00595	CbGpPWpGaD
Dronabinol—CYP1A1—Oxidative Stress—MAOA—attention deficit hyperactivity disorder	0.00479	0.00589	CbGpPWpGaD
Dronabinol—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00479	0.0258	CbGeAlD
Dronabinol—CNR1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00476	0.00584	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.0047	0.00578	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00461	0.00566	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00451	0.00553	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00448	0.0055	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00439	0.00539	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00437	0.00537	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00436	0.00536	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00429	0.00527	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00424	0.0052	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00424	0.0052	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00422	0.00519	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00416	0.00511	CbGpPWpGaD
Dronabinol—CNR2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00411	0.00505	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00411	0.00505	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00407	0.00499	CbGpPWpGaD
Dronabinol—CYP2C19—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00403	0.00495	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00398	0.00489	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00395	0.00485	CbGpPWpGaD
Dronabinol—CNR2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00383	0.0047	CbGpPWpGaD
Dronabinol—CYP1A1—nervous system—attention deficit hyperactivity disorder	0.00374	0.0201	CbGeAlD
Dronabinol—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00371	0.02	CbGeAlD
Dronabinol—CNR1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00369	0.00453	CbGpPWpGaD
Dronabinol—CYP1A1—central nervous system—attention deficit hyperactivity disorder	0.0036	0.0194	CbGeAlD
Dronabinol—CNR2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00358	0.0044	CbGpPWpGaD
Dronabinol—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00358	0.0193	CbGeAlD
Dronabinol—CYP3A4—Estrogen metabolism—COMT—attention deficit hyperactivity disorder	0.00357	0.00439	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00352	0.00433	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00351	0.00432	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00344	0.00423	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00343	0.00421	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00332	0.00408	CbGpPWpGaD
Dronabinol—PTGS1—nervous system—attention deficit hyperactivity disorder	0.00329	0.0177	CbGeAlD
Dronabinol—CNR1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00327	0.00401	CbGpPWpGaD
Dronabinol—CNR1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00323	0.00396	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00323	0.00396	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00319	0.00392	CbGpPWpGaD
Dronabinol—PTGS1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00317	0.00389	CbGpPWpGaD
Dronabinol—PTGS1—central nervous system—attention deficit hyperactivity disorder	0.00316	0.017	CbGeAlD
Dronabinol—CNR1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00313	0.00384	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00304	0.00373	CbGpPWpGaD
Dronabinol—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00303	0.0163	CbGeAlD
Dronabinol—ABCG2—brain—attention deficit hyperactivity disorder	0.00301	0.0162	CbGeAlD
Dronabinol—CNR1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00301	0.00369	CbGpPWpGaD
Dronabinol—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.003	0.00368	CbGpPWpGaD
Dronabinol—CYP1A1—brain—attention deficit hyperactivity disorder	0.00286	0.0154	CbGeAlD
Dronabinol—CNR1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00281	0.00345	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.0028	0.00343	CbGpPWpGaD
Dronabinol—ABCG2—HIF-2-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00277	0.0034	CbGpPWpGaD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00276	0.00339	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00276	0.00339	CbGpPWpGaD
Dronabinol—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00274	0.0148	CbGeAlD
Dronabinol—CNR2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00268	0.00329	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00266	0.00326	CbGpPWpGaD
Dronabinol—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00264	0.0142	CbGeAlD
Dronabinol—PTGS1—brain—attention deficit hyperactivity disorder	0.00251	0.0135	CbGeAlD
Dronabinol—CNR2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00247	0.00304	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00241	0.00296	CbGpPWpGaD
Dronabinol—CYP2A6—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.00241	0.00296	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.0024	0.00295	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00239	0.00294	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00239	0.00293	CbGpPWpGaD
Dronabinol—ABCB1—midbrain—attention deficit hyperactivity disorder	0.00236	0.0127	CbGeAlD
Dronabinol—CNR2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00235	0.00289	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00235	0.00289	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00232	0.00285	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00231	0.00283	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00224	0.00276	CbGpPWpGaD
Dronabinol—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00223	0.00274	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00219	0.00269	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00218	0.00267	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00217	0.00267	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00217	0.00266	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.00216	0.00266	CbGpPWpGaD
Dronabinol—CYP2A6—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.00215	0.00264	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00214	0.00262	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00211	0.00259	CbGpPWpGaD
Dronabinol—CNR1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00211	0.00259	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00209	0.00256	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00208	0.00255	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00197	0.00241	CbGpPWpGaD
Dronabinol—ABCB1—nervous system—attention deficit hyperactivity disorder	0.00194	0.0105	CbGeAlD
Dronabinol—CNR1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00194	0.00238	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00189	0.00233	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00189	0.00232	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00188	0.00231	CbGpPWpGaD
Dronabinol—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.00187	0.0101	CbGeAlD
Dronabinol—CNR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00185	0.00227	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00185	0.00227	CbGpPWpGaD
Dronabinol—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.00183	0.00984	CbGeAlD
Dronabinol—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00183	0.00224	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00182	0.00224	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00181	0.00222	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00176	0.00216	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00171	0.00209	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0017	0.00209	CbGpPWpGaD
Dronabinol—PTGS1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00169	0.00208	CbGpPWpGaD
Dronabinol—PTGS1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00168	0.00207	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00168	0.00206	CbGpPWpGaD
Dronabinol—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00167	0.00205	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00166	0.00203	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00163	0.002	CbGpPWpGaD
Dronabinol—ABCG2—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00163	0.002	CbGpPWpGaD
Dronabinol—CYP2A6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.0016	0.00197	CbGpPWpGaD
Dronabinol—CYP2A6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00159	0.00195	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00154	0.00189	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00152	0.00186	CbGpPWpGaD
Dronabinol—ABCB1—brain—attention deficit hyperactivity disorder	0.00148	0.008	CbGeAlD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	0.00147	0.00181	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	0.00147	0.00181	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00143	0.00175	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00138	0.00169	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00133	0.00163	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00128	0.00158	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00128	0.00157	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00126	0.00155	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00125	0.00153	CbGpPWpGaD
Dronabinol—CYP1A1—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00119	0.00147	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00119	0.00146	CbGpPWpGaD
Dronabinol—CYP1A1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00119	0.00146	CbGpPWpGaD
Dronabinol—CYP1A1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00118	0.00145	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00118	0.00145	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00116	0.00143	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.00112	0.00138	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00112	0.00137	CbGpPWpGaD
Dronabinol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.0011	0.00135	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00108	0.00133	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00104	0.00128	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00101	0.00124	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00099	0.00122	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000978	0.0012	CbGpPWpGaD
Dronabinol—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000977	0.0012	CbGpPWpGaD
Dronabinol—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.00097	0.00119	CbGpPWpGaD
Dronabinol—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000964	0.00118	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000911	0.00112	CbGpPWpGaD
Dronabinol—CYP2C9—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000891	0.00109	CbGpPWpGaD
Dronabinol—CYP2C9—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000885	0.00109	CbGpPWpGaD
Dronabinol—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	0.00088	0.00108	CbGpPWpGaD
Dronabinol—CYP2C9—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000879	0.00108	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.00084	0.00103	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000813	0.000999	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000757	0.00093	CbGpPWpGaD
Dronabinol—CYP1A1—PPARA activates gene expression—EP300—attention deficit hyperactivity disorder	0.000732	0.000899	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000721	0.000886	CbGpPWpGaD
Dronabinol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—attention deficit hyperactivity disorder	0.000717	0.00088	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000693	0.000851	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000655	0.000805	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000638	0.000784	CbGpPWpGaD
Dronabinol—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000588	0.000722	CbGpPWpGaD
Dronabinol—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000583	0.000716	CbGpPWpGaD
Dronabinol—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.00058	0.000712	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000498	0.000611	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000498	0.000611	CbGpPWpGaD
Dronabinol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—attention deficit hyperactivity disorder	0.000494	0.000606	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00049	0.000602	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000488	0.0006	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000478	0.000587	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000478	0.000587	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000471	0.000578	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000455	0.000559	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000452	0.000556	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000452	0.000556	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000445	0.000547	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000438	0.000537	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000431	0.000529	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000414	0.000508	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.00041	0.000503	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.0004	0.000491	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000398	0.000489	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00039	0.000479	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000382	0.00047	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000379	0.000465	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	0.000376	0.000462	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000364	0.000447	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000364	0.000447	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000362	0.000444	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000344	0.000423	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000338	0.000415	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000337	0.000414	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000337	0.000414	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000332	0.000407	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000308	0.000379	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	0.000302	0.00037	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	0.0003	0.000368	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—COMT—attention deficit hyperactivity disorder	0.00029	0.000356	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000288	0.000353	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000279	0.000343	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000276	0.000339	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000276	0.000339	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000274	0.000337	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000272	0.000334	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000271	0.000333	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000269	0.000331	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000269	0.000331	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000269	0.000331	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000265	0.000325	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000256	0.000315	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000252	0.00031	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000251	0.000309	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000251	0.000309	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000247	0.000304	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000246	0.000302	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00024	0.000295	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.00023	0.000282	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00022	0.000271	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000215	0.000264	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00021	0.000258	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000205	0.000252	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000204	0.000251	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000203	0.000249	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000201	0.000247	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000197	0.000241	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000191	0.000235	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	0.000167	0.000205	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000166	0.000204	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000166	0.000204	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000166	0.000204	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000163	0.0002	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	0.000163	0.0002	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000162	0.000199	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000161	0.000198	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—COMT—attention deficit hyperactivity disorder	0.000152	0.000187	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000152	0.000186	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000151	0.000186	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	0.000147	0.00018	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000133	0.000163	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	0.000129	0.000159	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000126	0.000155	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—EP300—attention deficit hyperactivity disorder	0.000124	0.000153	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—EP300—attention deficit hyperactivity disorder	0.000118	0.000144	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	0.0001	0.000123	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	9.98e-05	0.000123	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—EP300—attention deficit hyperactivity disorder	8.76e-05	0.000108	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	7.17e-05	8.8e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	6.99e-05	8.59e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—EP300—attention deficit hyperactivity disorder	6.53e-05	8.02e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	4.31e-05	5.29e-05	CbGpPWpGaD
